Tia L.

Bioverge is a financial technology and investment platform bringing science fiction to life. We provide access to accredited investors, family offices, registered investment advisors, and others to invest alongside us and other top institutions in highly-vetted healthcare startups. We offer a variety of investment options, personalized to the unique needs of our investors including deal-by-deal investments, Access Funds, and Thematic Funds focused on specific technologies or diseases.

Republic is a financial technology firm specializing in private market investment services. Republic operates a marketplace platform for community finance, accredited investment opportunities, full-service tokenization, digital asset management, blockchain advisory, and private institutional capital. Republic has deployed over $2.6 billion in investments, supported over 2,500 ventures, with a community of over 3M users across 150 countries. Republic is backed by dozens of leading investment firms and financial institutions and has co-invested with the best names in venture and private equity. Founded in 2016, Republic is headquartered in New York City with offices worldwide. For additional information, visit republic.com or @joinrepublic on X. Worth building™

Black Latin-X Indigenouse Institutes for Health (BLIIH) is a non-profit for BIPOC Life Science Research and Workforce Training. Its founding members are LucasPye BIO & HelaPlex. We work in partnership with our fidiciary partner - Urban Affairs Coalition (UAC). BLIIH demonstrates its support via the development and implementation of the following programs (in order of priority): 1. Financially support the HelaPlex Biotechnology Workforce Development Training Program 2. Propose Public Policy on African-Diasporic, Caribbean, Indigenous & Latin-X Health Disparities / Clinical Trial Diversity 3. Provide Incubator Lab Space at HBCUs & African Diasporic, Caribbean, Indigenous & Latin-X Universities, i.e., IncubateBLIIH 4. Provide Commercialization Support for African-Diasporic, Caribbean, Indigenous & Latin-X Life Science Start-Up Assets via HelaPlex Accelerator 5. Develop Regulatory Infrastructure for Drug / Device Commercialization in African- Diasporic, Caribbean, Indigenous & Latin-X Countries

A network for entrepreneurs building in stealth. Submit your information here so investors can find you: harmonic.ai/get-discovered

An AI/ML Genomics & Therapeutics R&D firm focused on mapping the Human Genome for Underserved Community Members to remove health disparities and commercializing therapeutics for equitable healthcare. We are sequencing the Human Genome for Undeserved Community Members ; developing/commercializing biologic drugs to treat diseases/viruses that significantly impact Underserved Community Members most; and providing a pathway to close the wealth gap within Underserved Communities by building a sustainable Informed Consent program that allows Research Participants to generate revenue from their genetic donations via both short-term/long-term U.S. Currency Payment Opportunities. Launched at Founder Institute - 2023 Toronto, Canada Cohort

HiveBio, a first-of-its-kind virtual accelerator program founded by HelaPlex, is your gateway to success. Created by underrepresented founders for underrepresented founders, we’re on a mission to reshape the landscape of life science startups globally. We work in partnership with LaunchBio and WorldUpstart. Our accelerator program educates and coaches entrepreneurs on six (6) key elements: 1. Telling Your Story 2. Discovering your Customer 3. Confirming a Strategy 4. Drafting Financial Projections 5. SBIR/STTR Fundraising 6. Angel Investment/VC Funding Stay informed and receive updates on our upcoming HiveBio 2025 PreSeed/Seed pilot program via sponsorship from The Knight Foundation. Click our website below for more information.

Bioverge is a financial technology and investment platform bringing science fiction to life. We provide access to accredited investors, family offices, registered investment advisors, and others to invest alongside us and other top institutions in highly-vetted healthcare startups. We offer a variety of investment options, personalized to the unique needs of our investors including deal-by-deal investments, Access Funds, and Thematic Funds focused on specific technologies or diseases.